Logo

RNA-based Therapeutics and Vaccines Market Size, Share, Growth, and Regional Forecast, 2026 to 2033

RNA-based Therapeutics and Vaccines Market by Product (RNA-based Therapeutics, RNA-based Vaccines), Indication Type (Oncology, Immunology, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Genetic Diseases, Others), and Regional Analysis from 2026 to 2033.

ID: PMRREP12868
Calendar

January 2026

199 Pages

Author : Pravin Rewale

Healthcare
  1. Executive Summary
    1. Global RNA-based Therapeutics and Vaccines Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 – 2033, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors – Relevance and Impact
  3. Value Added Insights
    1. Regulatory Landscape
    2. Product Adoption Analysis
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. PESTLE Analysis
    6. Porter’s Five Force Analysis
  4. Global RNA-based Therapeutics and Vaccines Market Outlook:
    1. Key Highlights
      1. Market Size (US$ Mn) and Y-o-Y Growth
      2. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2020-2025
      2. Market Size (US$ Mn) Analysis and Forecast, 2026–2033
    3. Global RNA-based Therapeutics and Vaccines Market Outlook: Product
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Product, 2020 – 2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Product, 2026 – 2033
        1. RNA-based Therapeutics
          1. siRNA
          2. miRNA
        2. RNA-based Vaccines
          1. mRNA
      4. Market Attractiveness Analysis: Product
    4. Global RNA-based Therapeutics and Vaccines Market Outlook: Indication Type
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Indication Type, 2020 – 2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Indication Type, 2026 – 2033
        1. Oncology
        2. Immunology
        3. Ophthalmology
        4. Cardiovascular Diseases
        5. Infectious Diseases
        6. Genetic Diseases
        7. Others
      4. Market Attractiveness Analysis: Indication Type
  5. Global RNA-based Therapeutics and Vaccines Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Region, 2020 – 2025
    3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2026 – 2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America RNA-based Therapeutics and Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Indication Type
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
      1. U.S.
      2. Canada
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2026 – 2033
      1. RNA-based Therapeutics
        1. siRNA
        2. miRNA
      2. RNA-based Vaccines
        1. mRNA
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication Type, 2026 – 2033
      1. Oncology
      2. Immunology
      3. Ophthalmology
      4. Cardiovascular Diseases
      5. Infectious Diseases
      6. Genetic Diseases
      7. Others
    6. Market Attractiveness Analysis
  7. Europe RNA-based Therapeutics and Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Indication Type
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2026 – 2033
      1. RNA-based Therapeutics
        1. siRNA
        2. miRNA
      2. RNA-based Vaccines
        1. mRNA
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication Type, 2026 – 2033
      1. Oncology
      2. Immunology
      3. Ophthalmology
      4. Cardiovascular Diseases
      5. Infectious Diseases
      6. Genetic Diseases
      7. Others
    6. Market Attractiveness Analysis
  8. East Asia RNA-based Therapeutics and Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Indication Type
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2026 – 2033
      1. RNA-based Therapeutics
        1. siRNA
        2. miRNA
      2. RNA-based Vaccines
        1. mRNA
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication Type, 2026 – 2033
      1. Oncology
      2. Immunology
      3. Ophthalmology
      4. Cardiovascular Diseases
      5. Infectious Diseases
      6. Genetic Diseases
      7. Others
    6. Market Attractiveness Analysis
  9. South Asia & Oceania RNA-based Therapeutics and Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Indication Type
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2026 – 2033
      1. RNA-based Therapeutics
        1. siRNA
        2. miRNA
      2. RNA-based Vaccines
        1. mRNA
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication Type, 2026 – 2033
      1. Oncology
      2. Immunology
      3. Ophthalmology
      4. Cardiovascular Diseases
      5. Infectious Diseases
      6. Genetic Diseases
      7. Others
    6. Market Attractiveness Analysis
  10. Latin America RNA-based Therapeutics and Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Indication Type
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2026 – 2033
      1. RNA-based Therapeutics
        1. siRNA
        2. miRNA
      2. RNA-based Vaccines
        1. mRNA
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication Type, 2026 – 2033
      1. Oncology
      2. Immunology
      3. Ophthalmology
      4. Cardiovascular Diseases
      5. Infectious Diseases
      6. Genetic Diseases
      7. Others
    6. Market Attractiveness Analysis
  11. Middle East & Africa RNA-based Therapeutics and Vaccines Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020 – 2025
      1. By Country
      2. By Product
      3. By Indication Type
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026 – 2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Product, 2026 – 2033
      1. RNA-based Therapeutics
        1. siRNA
        2. miRNA
      2. RNA-based Vaccines
        1. mRNA
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication Type, 2026 – 2033
      1. Oncology
      2. Immunology
      3. Ophthalmology
      4. Cardiovascular Diseases
      5. Infectious Diseases
      6. Genetic Diseases
      7. Others
    6. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
      1. Alnylam Pharmaceuticals, Inc.
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Arbutus Biopharma Corp.
      3. Arrowhead Pharmaceuticals, Inc.
      4. BioNTech AG
      5. CureVac AG
      6. Dicerna Pharmaceuticals, Inc.
      7. Regulus Therapeutics, Inc.
      8. Marina Biotech, Inc.
      9. miRagen Therapeutics
      10. Moderna Therapeutics, Inc.
      11. Quark Pharmaceuticals, Inc.
      12. Santaris Pharma A/S (A Roche Company)
      13. Sylentis S.A.
      14. Others   
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations

 

Emailsales@persistencemarketresearch.com
UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

+91 906 779 3500SIN : +65 6531 3894 98
Quick Links
CareersTerms & ConditionsReturn PolicyMarket Research Report
Customer FAQ’sPrivacy PolicySitemap

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -